Biohaven (BHVN) Short-term Investments (2022 - 2026)
Biohaven's (BHVN) quarterly Short-term Investments came in at $74.7 million in Q1 2026, down 66.68% year-on-year from $224.3 million in Q1 2025, and down 16.19% quarter-over-quarter from $89.2 million in Q4 2025.
Biohaven (BHVN) Short-term Investments (2022 - 2026) Analysis & Trends
Biohaven has disclosed Short-term Investments across 5 years of filings, most recently posting $74.7 million for Q1 2026.
- Short-term Investments for Q1 2026 came in at $74.7 million, down 66.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $74.7 million (down 66.68% YoY), and the FY2025 annual result was $89.2 million, down 76.95% from the prior year.
- Short-term Investments came in at $74.7 million for Q1 2026 at Biohaven, down from $89.2 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $386.9 million in Q4 2024 to a low of $40.4 million in Q2 2023.
- The 5-year median for Short-term Investments is $165.6 million (2023), against an average of $179.2 million.
- Across the five-year window, Short-term Investments jumped 389.42% in 2024 and slumped 76.95% in 2025, its largest moves.
- Biohaven's Short-term Investments stood at $260.5 million in 2022, then tumbled by 48.78% to $133.4 million in 2023, then surged by 189.96% to $386.9 million in 2024, then plunged by 76.95% to $89.2 million in 2025, then retreated by 16.19% to $74.7 million in 2026.
- The last three Short-term Investments figures came in at $74.7 million (Q1 2026), $89.2 million (Q4 2025), and $75.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.74 Mn |
| Dec 31, 2025 | 89.18 Mn |
| Sep 30, 2025 | 75.37 Mn |
| Jun 30, 2025 | 239.18 Mn |
| Mar 31, 2025 | 224.33 Mn |
| Dec 31, 2024 | 386.86 Mn |
| Sep 30, 2024 | 294.43 Mn |
| Jun 30, 2024 | 197.80 Mn |
| Mar 31, 2024 | 100.71 Mn |
| Dec 31, 2023 | 133.42 Mn |
| Sep 30, 2023 | 128.90 Mn |
| Jun 30, 2023 | 40.42 Mn |
| Mar 31, 2023 | 263.00 Mn |
| Dec 31, 2022 | 260.46 Mn |